Cittadine Andrew
Transaction: 03/31/2026
SELL
Change
-3,514
Price
Not reported
Filing
04/02/2026
Type
SELL
Monopar Therapeutics Inc.
MNPR • Biotechnology
$117.56
▼ -0.99 (-0.84%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.00B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 51.35Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 14, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$117.56
Change-0.84%
Shares Out8.54M
Market Cap$1.00B
Enterprise Value$865.88M
52W Range29.18 - 105.00
Beta1.66
P/E-66.96
P/B7.41
P/FCF-100.22
EV/EBITDA-48.30
EV/FCF-86.49
Price$117.56
Change-0.84%
Shares Out8.54M
Market Cap$1.00B
Enterprise Value$865.88M
52W Range29.18 - 105.00
Beta1.66
P/E-66.96
P/B7.41
P/FCF-100.22
EV/EBITDA-48.30
EV/FCF-86.49
Earnings Yield-1.49%
FCF Yield-1.00%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio51.35
Quick Ratio51.35
Target$123.57
Target Upside5.11%
Target Median$125.00
Target Range105.00 - 133.00
Volume272.43K
Avg Volume165.05K
EPS Surprise0.60
Investment DNA
How strong this company looks for long-term investors
44
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
74/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 51.35Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 14 analyst votes · 2026-09-05
89/100
Bullish
Bullish
11
Hold
3
Bearish
0
Price Target
2026-06-24
Low
$105.00
Mean
$110.00
Median
$110.00
High
$115.00
Insider Transactions
Recent executive and insider activity
Cittadine Andrew
Transaction: 03/31/2026
SELL
Change
-1,571
Price
$54.79
Filing
04/02/2026
Type
SELL
Robinson Chandler
Transaction: 03/31/2026
SELL
Change
-1,972
Price
$54.79
Filing
04/02/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Cittadine Andrew | SELL | -3,514 | Not reported | 03/31/2026 | 04/02/2026 |
| Cittadine Andrew | SELL | -1,571 | $54.79 | 03/31/2026 | 04/02/2026 |
| Robinson Chandler | SELL | -1,972 | $54.79 | 03/31/2026 | 04/02/2026 |
| Robinson Chandler | SELL | -6,732 | Not reported | 03/31/2026 | 04/02/2026 |
| Rodriguez Susan | OTHER | 0 | Not reported | 03/02/2026 | 03/04/2026 |
| Rodriguez Susan | BUY | +48,728 | $53.47 | 03/02/2026 | 03/04/2026 |
| Robinson Chandler | BUY | +62,815 | Not reported | 01/28/2025 | 01/30/2026 |
| RIOUX PATRICE | BUY | +2,000 | $65.30 | 01/01/2026 | 01/05/2026 |
| Cittadine Andrew | SELL | -4,326 | Not reported | 12/31/2025 | 01/05/2026 |
| Cittadine Andrew | SELL | -1,889 | $65.30 | 12/31/2025 | 01/05/2026 |
| Robinson Chandler | SELL | -2,558 | $65.30 | 12/31/2025 | 01/05/2026 |
| Robinson Chandler | SELL | -8,724 | Not reported | 12/31/2025 | 01/05/2026 |
| Vu Quan Anh | BUY | +1,500 | $69.95 | 12/26/2025 | 12/29/2025 |
| KLAUSNER ARTHUR J | SELL | -461 | $68.09 | 12/18/2025 | 12/19/2025 |
| KLAUSNER ARTHUR J | BUY | +7,710 | Not reported | 12/16/2025 | 12/17/2025 |
| Hendricks Diane | SELL | -43,499 | Not reported | 12/16/2025 | 12/17/2025 |
| Robinson Chandler | BUY | +16,753 | $75.94 | 12/02/2025 | 12/08/2025 |
| Robinson Chandler | BUY | +49,133 | Not reported | 12/02/2025 | 12/08/2025 |
| Vu Quan Anh | BUY | +7,135 | $75.94 | 12/02/2025 | 12/08/2025 |
| Vu Quan Anh | BUY | +9,826 | Not reported | 12/02/2025 | 12/08/2025 |